首页 > 最新文献

International Journal of Evidence-Based Healthcare最新文献

英文 中文
Better understanding of ‘don’t confuse absence of evidence with evidence of absence’ 更好地理解"不要混淆证据缺失和证据缺失"
Q3 Medicine Pub Date : 2019-10-17 DOI: 10.17267/2675-021xevidence.v1i2.2348
R. Pacheco, L. Fontes, A. Martimbianco, R. Riera
| INTRODUCTION: In every single lecture or text book of Evidence-based Health-care and research synthesis, we invariably find references to the aphorism “absence of evidence does not mean absence of effect”. However, we have not rarely found those who forget, ignore or put this aphorism aside while interpreting results from research on healthcare. The objective of this text is to clarify the concepts underlying this aphorism, such as absence of evidence and absence of effect.
导言:在每一个以证据为基础的卫生保健和研究综合的讲座或教科书中,我们总是发现这句格言“缺乏证据并不意味着没有效果”。然而,我们很少发现那些在解释医疗保健研究结果时忘记、忽视或把这句格言放在一边的人。本文的目的是澄清这句格言背后的概念,如缺乏证据和缺乏效果。
{"title":"Better understanding of ‘don’t confuse absence of evidence with evidence of absence’","authors":"R. Pacheco, L. Fontes, A. Martimbianco, R. Riera","doi":"10.17267/2675-021xevidence.v1i2.2348","DOIUrl":"https://doi.org/10.17267/2675-021xevidence.v1i2.2348","url":null,"abstract":"| INTRODUCTION: In every single lecture or text book of Evidence-based Health-care and research synthesis, we invariably find references to the aphorism “absence of evidence does not mean absence of effect”. However, we have not rarely found those who forget, ignore or put this aphorism aside while interpreting results from research on healthcare. The objective of this text is to clarify the concepts underlying this aphorism, such as absence of evidence and absence of effect.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"55 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83402802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect of respiratory muscle training session on ankle muscle activity in athletes with chronic low back pain performing overhead squats: a randomized controlled trial. 呼吸肌肉训练对慢性下蹲腰痛运动员踝关节肌肉活动的影响:一项随机对照试验。
Q3 Medicine Pub Date : 2019-09-20 DOI: 10.1097/XEB.0000000000000204
B. G. Borujeni, A. Yalfani
AIMThe current study was conducted to evaluate the effect of a respiratory muscle training session on ankle muscle activity in athletes with chronic low back pain performing overhead squats.METHODSThe current double-blind, randomized, controlled trial was conducted on 24 patients randomly selected as the training group and 23 patients as the control group. The training group received the respiratory muscle training protocol. The electromyography activity of the tibialis anterior, peroneus longus, gastrocnemius medialis and gastrocnemius lateralis muscles of the dominant leg was recorded in the participants.RESULTSThe findings showed that a session of respiratory muscle training reduced the activities of some ankle joint muscles when performing overhead squats, including tibialis anterior in the static and dynamic overhead squat tests and peroneus longus in the ascending phase. In the dynamic test, the angle to reach peak activity changed in tibialis anterior in the descending phase and also in tibialis anterior and peroneus longus in the ascending phase.CONCLUSIONEffects of respiratory muscle training prevented excessive ankle joint muscle activity through stimulating local muscles while performing overhead squats, which had indicated an improved postural control and multisectional proprioception to maintain postural stability and stimulated the local muscles of the core area.
本研究旨在评估呼吸肌肉训练对慢性腰痛运动员进行顶蹲训练时踝关节肌肉活动的影响。方法采用双盲、随机、对照试验,随机选择24例患者作为训练组,23例患者作为对照组。训练组采用呼吸肌训练方案。记录参与者优势腿胫骨前肌、腓长肌、腓肠肌内侧肌和腓肠肌外侧肌的肌电活动。结果研究结果表明,一段时间的呼吸肌训练减少了一些踝关节肌肉的活动,包括静态和动态深蹲测试中的胫骨前肌和上升阶段的腓骨长肌。在动态测试中,下降期胫骨前肌达到活动峰值的角度发生了变化,上升期胫骨前肌和腓骨长肌也发生了变化。结论呼吸肌训练通过刺激踝关节局部肌肉,抑制了踝关节肌肉过度活动,提高了体位控制和多段本体感觉,维持了体位稳定性,刺激了核心区域局部肌肉。
{"title":"Effect of respiratory muscle training session on ankle muscle activity in athletes with chronic low back pain performing overhead squats: a randomized controlled trial.","authors":"B. G. Borujeni, A. Yalfani","doi":"10.1097/XEB.0000000000000204","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000204","url":null,"abstract":"AIM\u0000The current study was conducted to evaluate the effect of a respiratory muscle training session on ankle muscle activity in athletes with chronic low back pain performing overhead squats.\u0000\u0000\u0000METHODS\u0000The current double-blind, randomized, controlled trial was conducted on 24 patients randomly selected as the training group and 23 patients as the control group. The training group received the respiratory muscle training protocol. The electromyography activity of the tibialis anterior, peroneus longus, gastrocnemius medialis and gastrocnemius lateralis muscles of the dominant leg was recorded in the participants.\u0000\u0000\u0000RESULTS\u0000The findings showed that a session of respiratory muscle training reduced the activities of some ankle joint muscles when performing overhead squats, including tibialis anterior in the static and dynamic overhead squat tests and peroneus longus in the ascending phase. In the dynamic test, the angle to reach peak activity changed in tibialis anterior in the descending phase and also in tibialis anterior and peroneus longus in the ascending phase.\u0000\u0000\u0000CONCLUSION\u0000Effects of respiratory muscle training prevented excessive ankle joint muscle activity through stimulating local muscles while performing overhead squats, which had indicated an improved postural control and multisectional proprioception to maintain postural stability and stimulated the local muscles of the core area.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"61 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88786229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The current state of heart disease: statins, cholesterol, fat and sugar. 心脏病现状:他汀类药物、胆固醇、脂肪和糖。
Q3 Medicine Pub Date : 2019-09-01 DOI: 10.1097/XEB.0000000000000197
Chrystyne Olivieri
After decades of improvement in the outlook for cardiovascular disease (CVD), we are now seeing a plateau. Statins, once believed to be the most important advance in the fight against heart disease, have not mitigated the incidence or prevalence of CVD.AIMNew research into lipid-lowering drugs is not only questioning their usefulness in primary care, but identifying them as harmful, resulting in the development of other diseases. When the original research is critically analyzed, the data do not reveal drugs that significantly reduce the incidence or prevalence for primary prevention of CVD in the United States.METHODSThe current article sheds light on our current beliefs into lipid-lowering to treat potential CVD. Through a discussion of the difference between relative risk reduction and absolute risk reduction, the author suggests lifestyle modifications have been and always will be the best way to fight against this deadly chronic disease.RESULTSThere is over 60 years-worth of scientific research that has been desperately trying to identify sugar as the culprit and driver of CVD disease; however, the medical system continues to fight against fat and cholesterol. This article makes the reader question what the US government, in association with the Medical Establishment (American Heart Association, American Diabetes Association and the American College of Cardiology) have been eschewing for the last 60-70 years as it has NOT been working.CONCLUSIONThe time for a culture-wide paradigm change has come. The author suggests this will only happen if Big Pharma and Big Food industries will change their marketing habits from 'purely taste' to 'best for your health'.
经过几十年心血管疾病(CVD)前景的改善,我们现在看到了一个平台期。他汀类药物,曾经被认为是对抗心脏病的最重要的进展,并没有降低心血管疾病的发病率或患病率。对降脂药物的新研究不仅质疑它们在初级保健中的作用,而且确定它们是有害的,会导致其他疾病的发展。当对原始研究进行批判性分析时,数据并没有显示药物显著降低美国心血管疾病一级预防的发病率或患病率。方法:本文阐明了我们目前对降脂治疗潜在心血管疾病的看法。通过讨论相对风险降低和绝对风险降低之间的区别,作者建议改变生活方式一直是并且永远是对抗这种致命慢性疾病的最佳方法。结果:60多年来的科学研究一直在努力确定糖是心血管疾病的罪魁祸首和驱动因素;然而,医疗系统仍在与脂肪和胆固醇作斗争。这篇文章让读者质疑,美国政府和医疗机构(美国心脏协会、美国糖尿病协会和美国心脏病学会)在过去的60-70年里一直在回避什么,因为它没有起作用。在整个文化范围内进行范式变革的时代已经到来。作者建议,只有大型制药公司和大型食品公司将他们的营销习惯从“纯粹的口味”转变为“对你的健康最好”,这才会发生。
{"title":"The current state of heart disease: statins, cholesterol, fat and sugar.","authors":"Chrystyne Olivieri","doi":"10.1097/XEB.0000000000000197","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000197","url":null,"abstract":"After decades of improvement in the outlook for cardiovascular disease (CVD), we are now seeing a plateau. Statins, once believed to be the most important advance in the fight against heart disease, have not mitigated the incidence or prevalence of CVD.\u0000\u0000\u0000AIM\u0000New research into lipid-lowering drugs is not only questioning their usefulness in primary care, but identifying them as harmful, resulting in the development of other diseases. When the original research is critically analyzed, the data do not reveal drugs that significantly reduce the incidence or prevalence for primary prevention of CVD in the United States.\u0000\u0000\u0000METHODS\u0000The current article sheds light on our current beliefs into lipid-lowering to treat potential CVD. Through a discussion of the difference between relative risk reduction and absolute risk reduction, the author suggests lifestyle modifications have been and always will be the best way to fight against this deadly chronic disease.\u0000\u0000\u0000RESULTS\u0000There is over 60 years-worth of scientific research that has been desperately trying to identify sugar as the culprit and driver of CVD disease; however, the medical system continues to fight against fat and cholesterol. This article makes the reader question what the US government, in association with the Medical Establishment (American Heart Association, American Diabetes Association and the American College of Cardiology) have been eschewing for the last 60-70 years as it has NOT been working.\u0000\u0000\u0000CONCLUSION\u0000The time for a culture-wide paradigm change has come. The author suggests this will only happen if Big Pharma and Big Food industries will change their marketing habits from 'purely taste' to 'best for your health'.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81406008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Implementation of an opioid weaning protocol to improve pain management, and to prevent or decrease iatrogenic withdrawal syndrome in the neonatal intensive care. 实施阿片类药物断奶方案,以改善疼痛管理,预防或减少新生儿重症监护中的医源性戒断综合征。
Q3 Medicine Pub Date : 2019-09-01 DOI: 10.1097/XEB.0000000000000169
Renee Muirhead, Kathryn Kynoch

Aim: The aim of this evidence implementation project was to improve pain assessment and management of the neonate receiving an opioid infusion, and to prevent or decrease the incidence of iatrogenic withdrawal syndrome (IWS).

Methods: The current project was carried out in two intensive care areas of a 79 bed tertiary Neonatal Unit in Australia. A pre/postaudit design was utilized. Patient charts were reviewed to collect baseline audit data on pain assessments and titration of opioids. A weaning protocol was developed and implemented along with targeted staff education to align current practice with best practice recommendations. A postimplementation audit was then conducted to evaluate changes in practice.

Results: A total of 32 charts (13 pre/19 post) were reviewed to evaluate pain assessment, titration of opioids, and the identification of any signs and symptoms of IWS. The results demonstrated an improvement in the completion of pain assessments by 34%, and 100% compliance to withdrawal assessment following the introduction of an IWS assessment tool. For neonates receiving analgesics for less than 4 days, adherence to the weaning schedule occurred in 75%. No clinical signs of IWS were seen in this cohort. For neonates receiving analgesics for greater than 4 days, adherence to the weaning schedule occurred in only 55%. Of those neonates where the protocol was not followed, 67% developed clinical signs of IWS.

Conclusion: Although this project demonstrated improvements in pain assessment and the identification of IWS, lack of adherence to the pain management policy and weaning tool has increased awareness of the importance of collaboration within the multidisciplinary team to improve outcomes. Several barriers were identified prior to implementation and various methods were employed to overcome these. Despite this, consistency of practice and change-management remain a challenge in clinical care.

目的:本证据实施项目旨在改善阿片类药物输注新生儿的疼痛评估和管理,预防或减少医源性戒断综合征(IWS)的发生。方法:目前的项目在澳大利亚79张床位的三级新生儿病房的两个重症监护区进行。采用了审计前/审计后设计。审查患者图表以收集疼痛评估和阿片类药物滴定的基线审计数据。制定并实施了断奶方案,同时对员工进行有针对性的教育,使当前做法与最佳做法建议保持一致。然后进行了实施后审计,以评价实践中的变化。结果:共审查了32张图表(13张术前/19张术后),以评估疼痛评估、阿片类药物的滴定以及IWS任何体征和症状的识别。结果显示,在引入IWS评估工具后,疼痛评估的完成率提高了34%,戒断评估的依从性达到100%。对于使用镇痛药少于4天的新生儿,遵守断奶计划的发生率为75%。该队列中未见IWS的临床症状。对于使用镇痛药超过4天的新生儿,只有55%的人遵守了断奶计划。在那些没有遵循方案的新生儿中,67%出现了IWS的临床症状。结论:尽管该项目显示了疼痛评估和IWS识别的改进,但缺乏对疼痛管理政策和脱机工具的遵守,增加了对多学科团队合作以改善结果的重要性的认识。在实施之前确定了几个障碍,并采用了各种方法来克服这些障碍。尽管如此,实践的一致性和变革管理仍然是临床护理的一个挑战。
{"title":"Implementation of an opioid weaning protocol to improve pain management, and to prevent or decrease iatrogenic withdrawal syndrome in the neonatal intensive care.","authors":"Renee Muirhead,&nbsp;Kathryn Kynoch","doi":"10.1097/XEB.0000000000000169","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000169","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this evidence implementation project was to improve pain assessment and management of the neonate receiving an opioid infusion, and to prevent or decrease the incidence of iatrogenic withdrawal syndrome (IWS).</p><p><strong>Methods: </strong>The current project was carried out in two intensive care areas of a 79 bed tertiary Neonatal Unit in Australia. A pre/postaudit design was utilized. Patient charts were reviewed to collect baseline audit data on pain assessments and titration of opioids. A weaning protocol was developed and implemented along with targeted staff education to align current practice with best practice recommendations. A postimplementation audit was then conducted to evaluate changes in practice.</p><p><strong>Results: </strong>A total of 32 charts (13 pre/19 post) were reviewed to evaluate pain assessment, titration of opioids, and the identification of any signs and symptoms of IWS. The results demonstrated an improvement in the completion of pain assessments by 34%, and 100% compliance to withdrawal assessment following the introduction of an IWS assessment tool. For neonates receiving analgesics for less than 4 days, adherence to the weaning schedule occurred in 75%. No clinical signs of IWS were seen in this cohort. For neonates receiving analgesics for greater than 4 days, adherence to the weaning schedule occurred in only 55%. Of those neonates where the protocol was not followed, 67% developed clinical signs of IWS.</p><p><strong>Conclusion: </strong>Although this project demonstrated improvements in pain assessment and the identification of IWS, lack of adherence to the pain management policy and weaning tool has increased awareness of the importance of collaboration within the multidisciplinary team to improve outcomes. Several barriers were identified prior to implementation and various methods were employed to overcome these. Despite this, consistency of practice and change-management remain a challenge in clinical care.</p>","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"17 3","pages":"147-156"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/XEB.0000000000000169","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37305718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evaluation of prescribing patterns of nonsteroidal anti-inflammatory agents in a tertiary setting. 评价非甾体抗炎药在三级设置的处方模式。
Q3 Medicine Pub Date : 2019-09-01 DOI: 10.1097/XEB.0000000000000173
Viviane Khalil, Wei Wang, Lauren Charlson, Samantha Blackley

Background: Non steroidal anti-inflammatory agents (NSAIDS) are among the most commonly prescribed analgesics despite their adverse effect profile. The main objective of this pilot study is to assess the prescribing patterns of NSAIDs in an Australian hospital and to examine predictors for prescribing patterns.

Method: A retrospective cross sectional study was conducted. Patients' gastrointestinal and cardiovascular comorbidities were recorded for stratifications according to international guidelines. Pharmacist input was recorded to examine its effect on NSAIDs' prescribing patterns. Appropriateness of prescribing patterns was determined according to published international prescribing guidelines for NSAIDs. Univariate and multivariate regression analyses were conducted to determine predictors of patients' variables on prescribing patterns.

Results: A total of 300 patients were eligible to be included in the study. Fifty-five percentage of patients audited were prescribed NSAIDs according to the guidelines. There was an association between the type of NSAIDs prescribed and patients' gastrointestinal and cardiovascular risks, P less than 0.01. Multiple logistic regression analysis has shown: age more than 75 years, a history of peptic ulcer disease or a moderate gastrointestinal risk were all predictors for receiving a NSAID with a gastroprotectant agent [odds ratio (OR) = 3.54, 95% confidence interval (CI) (1.10-11.79), P < 0.05; OR = 9.51, 95% CI (3.70-26.72), P < 0.01; and OR = 5.04, 95% CI (51.72-15.54), P < 0.01, respectively]. Naproxen was more likely to be prescribed in patients with moderate-to-high gastrointestinal risk [OR = 16.24, 95% CI (2.70-132.70) and OR = 81.47 95% CI (3.38-2436.53), P < 0.01, respectively]. Patients who had their medications reviewed by a pharmacist were prescribed cyclo-oxygenase-2 inhibitors more frequently [OR = 3.36, 95% CI (1.05-15.34), P < 0.05] than any other agent.

Conclusion: About half of the patients audited were prescribed NSAIDs appropriately. Factors affecting the prescribing of NSAIDs included: older age, patients' gastrointestinal risks as well as pharmacist input. This pilot study presents an opportunity for pharmacists to promote adherence to NSAIDs prescribing guidelines.

背景:非甾体抗炎药(NSAIDS)是最常用的处方镇痛药之一,尽管它们有不良反应。本初步研究的主要目的是评估澳大利亚一家医院非甾体抗炎药的处方模式,并检查处方模式的预测因素。方法:采用回顾性横断面研究。根据国际指南记录患者的胃肠道和心血管合并症进行分层。记录药剂师的意见,以检查其对非甾体抗炎药处方模式的影响。根据非甾体抗炎药国际处方指南确定处方模式的适宜性。进行单变量和多变量回归分析,以确定患者变量对处方模式的预测因子。结果:共有300例患者符合纳入研究的条件。55%的被审计患者根据指南开了非甾体抗炎药。处方非甾体抗炎药类型与患者胃肠道和心血管风险之间存在相关性,P < 0.01。多元logistic回归分析显示:年龄大于75岁、有消化性溃疡病史或有中等胃肠道风险均是接受非甾体抗炎药联合胃保护剂的预测因素[优势比(or) = 3.54, 95%可信区间(CI) (1.10-11.79), P]。结论:约有一半被审计的患者得到了适当的非甾体抗炎药处方。影响非甾体抗炎药处方的因素包括:年龄、患者胃肠道风险和药师投入。这项初步研究为药剂师提供了一个促进遵守非甾体抗炎药处方指南的机会。
{"title":"Evaluation of prescribing patterns of nonsteroidal anti-inflammatory agents in a tertiary setting.","authors":"Viviane Khalil,&nbsp;Wei Wang,&nbsp;Lauren Charlson,&nbsp;Samantha Blackley","doi":"10.1097/XEB.0000000000000173","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000173","url":null,"abstract":"<p><strong>Background: </strong>Non steroidal anti-inflammatory agents (NSAIDS) are among the most commonly prescribed analgesics despite their adverse effect profile. The main objective of this pilot study is to assess the prescribing patterns of NSAIDs in an Australian hospital and to examine predictors for prescribing patterns.</p><p><strong>Method: </strong>A retrospective cross sectional study was conducted. Patients' gastrointestinal and cardiovascular comorbidities were recorded for stratifications according to international guidelines. Pharmacist input was recorded to examine its effect on NSAIDs' prescribing patterns. Appropriateness of prescribing patterns was determined according to published international prescribing guidelines for NSAIDs. Univariate and multivariate regression analyses were conducted to determine predictors of patients' variables on prescribing patterns.</p><p><strong>Results: </strong>A total of 300 patients were eligible to be included in the study. Fifty-five percentage of patients audited were prescribed NSAIDs according to the guidelines. There was an association between the type of NSAIDs prescribed and patients' gastrointestinal and cardiovascular risks, P less than 0.01. Multiple logistic regression analysis has shown: age more than 75 years, a history of peptic ulcer disease or a moderate gastrointestinal risk were all predictors for receiving a NSAID with a gastroprotectant agent [odds ratio (OR) = 3.54, 95% confidence interval (CI) (1.10-11.79), P < 0.05; OR = 9.51, 95% CI (3.70-26.72), P < 0.01; and OR = 5.04, 95% CI (51.72-15.54), P < 0.01, respectively]. Naproxen was more likely to be prescribed in patients with moderate-to-high gastrointestinal risk [OR = 16.24, 95% CI (2.70-132.70) and OR = 81.47 95% CI (3.38-2436.53), P < 0.01, respectively]. Patients who had their medications reviewed by a pharmacist were prescribed cyclo-oxygenase-2 inhibitors more frequently [OR = 3.36, 95% CI (1.05-15.34), P < 0.05] than any other agent.</p><p><strong>Conclusion: </strong>About half of the patients audited were prescribed NSAIDs appropriately. Factors affecting the prescribing of NSAIDs included: older age, patients' gastrointestinal risks as well as pharmacist input. This pilot study presents an opportunity for pharmacists to promote adherence to NSAIDs prescribing guidelines.</p>","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"17 3","pages":"164-172"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/XEB.0000000000000173","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37066110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Developing and evaluating an intervention to improve care and reduce costs of rabies postexposure therapy: an observational quality improvement initiative in selected vaccination units in Sri Lanka. 制定和评估一项干预措施,以改善狂犬病暴露后治疗的护理和降低费用:斯里兰卡选定疫苗接种单位的一项观察性质量改进倡议。
Q3 Medicine Pub Date : 2019-09-01 DOI: 10.1097/XEB.0000000000000172
Pushpa U Gamalathge, Hannah E Carter, Omala Wimalaratne, Sanjeewa Kularatne

Background: Exposure to the rabies virus is fatal unless a patient is treated with a timely, accurate and complete administration of postexposure prophylaxis (PEP). The level of adherence to PEP guidelines by health service providers is therefore critical in providing high-quality care as well as preventing unnecessary costs.

Methods: We developed a simple user-friendly decision aid based on Sri Lankan national guidelines for the administration of PEP and trialed it over a 5-month period in three study settings. Pre and post levels of adherence to the national guidelines by service providers was measured in each setting. Changes to per patient cost for rabies medications and hospital admissions were also collected.

Results: A significant improvement in adherence to the guidelines was observed in two settings with a nonsignificant improvement observed in the third setting. We estimated a total cost saving of LKR 158 476 across the three sites, comprising LKR 14 418 in admissions cost savings and LKR 144 058 in medication savings.

Conclusion: We conclude that the development of a decision aid for the administration of PEP is likely to be an effective and cost-saving intervention in the Sri Lankan setting. Further research is required to inform the generalizability of our findings.

背景:暴露于狂犬病毒是致命的,除非患者得到及时、准确和完整的暴露后预防(PEP)治疗。因此,卫生服务提供者对PEP准则的遵守程度对于提供高质量护理和防止不必要的费用至关重要。方法:我们根据斯里兰卡国家PEP管理指南开发了一种简单易用的决策辅助工具,并在三个研究环境中进行了为期5个月的试验。在每一种情况下,对服务提供者遵守国家指导方针的前后水平进行了测量。还收集了每位患者狂犬病药物和住院费用的变化情况。结果:在两种情况下观察到遵循指南的显著改善,而在第三种情况下观察到无显著改善。我们估计三个地点的总成本节省为158 476卢比,其中包括住院费用节省14 418卢比和药物费用节省144 058卢比。结论:我们的结论是,在斯里兰卡环境下,为PEP的管理开发决策援助可能是一种有效且节省成本的干预措施。需要进一步的研究来证实我们的发现的普遍性。
{"title":"Developing and evaluating an intervention to improve care and reduce costs of rabies postexposure therapy: an observational quality improvement initiative in selected vaccination units in Sri Lanka.","authors":"Pushpa U Gamalathge,&nbsp;Hannah E Carter,&nbsp;Omala Wimalaratne,&nbsp;Sanjeewa Kularatne","doi":"10.1097/XEB.0000000000000172","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000172","url":null,"abstract":"<p><strong>Background: </strong>Exposure to the rabies virus is fatal unless a patient is treated with a timely, accurate and complete administration of postexposure prophylaxis (PEP). The level of adherence to PEP guidelines by health service providers is therefore critical in providing high-quality care as well as preventing unnecessary costs.</p><p><strong>Methods: </strong>We developed a simple user-friendly decision aid based on Sri Lankan national guidelines for the administration of PEP and trialed it over a 5-month period in three study settings. Pre and post levels of adherence to the national guidelines by service providers was measured in each setting. Changes to per patient cost for rabies medications and hospital admissions were also collected.</p><p><strong>Results: </strong>A significant improvement in adherence to the guidelines was observed in two settings with a nonsignificant improvement observed in the third setting. We estimated a total cost saving of LKR 158 476 across the three sites, comprising LKR 14 418 in admissions cost savings and LKR 144 058 in medication savings.</p><p><strong>Conclusion: </strong>We conclude that the development of a decision aid for the administration of PEP is likely to be an effective and cost-saving intervention in the Sri Lankan setting. Further research is required to inform the generalizability of our findings.</p>","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"17 3","pages":"157-163"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/XEB.0000000000000172","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37371339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological research: open questions, the need for 'research on research' and its implications for evidence-based health care and reducing research waste. 方法学研究:开放性问题、“关于研究的研究”的必要性及其对循证卫生保健和减少研究浪费的影响。
Q3 Medicine Pub Date : 2019-09-01 DOI: 10.1097/XEB.0000000000000201
L. Puljak
With the ever increasing pace of research reports published, a new type of study has emerged, in which researchers analyze research practices and provide methodological guidance for the future. The overall aims of such studies are to explore planning, conduct, reporting, dissemination, and evaluation of research, and to provide recommendations for their improvement. A myriad of studies have shown that studies are planned, conducted and reported in a suboptimal way, and that there is ample room for improvement. It has been suggested that studies with inadequate planning, conduct and reporting represent avoidable research waste, causing enormous waste of funds and researchers’ efforts, and yielding suboptimal research reports. Methodological studies represent research efforts that may help in reducing research waste, and therefore should be welcomed as a valuable contribution that may contribute to production of better evidence and justify investments in research. However, there are multiple open questions about what exactly is analyzed in such studies, which collective name we should use for them, what type of study designs can be considered methodological studies, are they synonymous with systematic reviews and metaanalyses (SR/MA), and so on. Methodological studies may be observational or interventional. The unit of analysis in observational methodological studies can be broadly described as a research-related report. Such reports can be very diverse, including, but not limited to, study protocols, datasets, full reports with data analyses, and summary formats such as abstracts, plain language summaries, and so on. These reports may or may not be published in peerreviewed literature. Some of those research-related reports that are not published in peer-reviewed literature are available online, including materials posted in registries and repositories, or organizational web sites. Interventional methodological studies explore various interventions for improving research.
随着研究报告发表速度的不断加快,出现了一种新的研究类型,即研究人员对研究实践进行分析,并为未来提供方法指导。这些研究的总体目标是探讨研究的规划、实施、报告、传播和评价,并为改进这些研究提出建议。无数的研究表明,研究的计划、执行和报告都不是最理想的方式,还有很大的改进空间。有人认为,规划、实施和报告不充分的研究是可以避免的研究浪费,造成资金和研究人员努力的巨大浪费,并产生不理想的研究报告。方法学研究代表着可能有助于减少研究浪费的研究努力,因此应该受到欢迎,因为它可能有助于产生更好的证据并证明研究投资的合理性。然而,在这些研究中究竟分析了什么,我们应该为它们使用哪个集体名称,什么类型的研究设计可以被认为是方法学研究,它们是否等同于系统评价和荟萃分析(SR/MA),等等,都有许多悬而未决的问题。方法学研究可以是观察性的或干预性的。观察方法学研究中的分析单元可以广义地描述为与研究相关的报告。这样的报告可以非常多样化,包括但不限于研究协议、数据集、带有数据分析的完整报告,以及摘要格式(如摘要、普通语言摘要等)。这些报告可能会也可能不会发表在同行评议的文献中。一些未在同行评议文献中发表的与研究相关的报告可在网上获得,包括发布在注册和存储库或组织网站上的材料。干预方法学研究探索各种干预措施以改进研究。
{"title":"Methodological research: open questions, the need for 'research on research' and its implications for evidence-based health care and reducing research waste.","authors":"L. Puljak","doi":"10.1097/XEB.0000000000000201","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000201","url":null,"abstract":"With the ever increasing pace of research reports published, a new type of study has emerged, in which researchers analyze research practices and provide methodological guidance for the future. The overall aims of such studies are to explore planning, conduct, reporting, dissemination, and evaluation of research, and to provide recommendations for their improvement. A myriad of studies have shown that studies are planned, conducted and reported in a suboptimal way, and that there is ample room for improvement. It has been suggested that studies with inadequate planning, conduct and reporting represent avoidable research waste, causing enormous waste of funds and researchers’ efforts, and yielding suboptimal research reports. Methodological studies represent research efforts that may help in reducing research waste, and therefore should be welcomed as a valuable contribution that may contribute to production of better evidence and justify investments in research. However, there are multiple open questions about what exactly is analyzed in such studies, which collective name we should use for them, what type of study designs can be considered methodological studies, are they synonymous with systematic reviews and metaanalyses (SR/MA), and so on. Methodological studies may be observational or interventional. The unit of analysis in observational methodological studies can be broadly described as a research-related report. Such reports can be very diverse, including, but not limited to, study protocols, datasets, full reports with data analyses, and summary formats such as abstracts, plain language summaries, and so on. These reports may or may not be published in peerreviewed literature. Some of those research-related reports that are not published in peer-reviewed literature are available online, including materials posted in registries and repositories, or organizational web sites. Interventional methodological studies explore various interventions for improving research.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"116 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81308303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Analysis of completeness of reporting utilizing the Reporting Items for practice Guidelines in Healthcare Statement in gastroenterology clinical practice guidelines. 利用胃肠病学临床实践指南中医疗声明实践指南报告项目的报告完整性分析。
Q3 Medicine Pub Date : 2019-09-01 DOI: 10.1097/XEB.0000000000000174
Benjamin Howard, Chris Chapman, Chase Meyer, Corbin Walters, Matt Vassar

Aim: Assessing reporting quality is important as it allows distinctions to be made between poor methodology and poor reporting practices. The Reporting Items for practice Guidelines in Healthcare (RIGHT) Statement checklist was published in 2017 to improve the thoroughness and reporting quality of clinical practice guidelines (CPGs). CPGs are evidence-based recommendations developed to assist clinician decision-making in the diagnosis and management of patients. The aim of this study is to assess the completeness of reporting in CPGs listed by the American College of Gastroenterology (ACG) and their frequency of reporting items listed in the RIGHT Statement.

Methods: Using the 22 criteria (35 items) of the RIGHT Statement checklist, two researchers independently documented the adherence to each item for all eligible guidelines listed by the ACG. This study was conducted from 01/10/18 to 05/12/18. Data were recorded onto a prespecified Google data abstraction form and extracted into MS Excel for statistical analysis.

Results: Out of 38 eligible guidelines, nine of the 35 RIGHT (25.7%) checklist items were met with less than 50% adherence. The mean adherence was 26.8 (SD ± 9.5); median adherence was 30 (interquartile range 21.5-33.5). The publication dates ranged from 2007 to 2017 with seven of the guidelines (18.4%) published between 2007 and 2009, 11 (29%) published between 2010 and 2013, and 20 (52.6%) published between 2014 and 2017.

Conclusion: The completeness of reporting in CPGs listed by the ACG remains inadequate in several key areas. Poor adherence to items of the RIGHT Statement checklist demonstrates that there is area for improvement in reporting quality.

目的:评估报告质量是重要的,因为它允许区分糟糕的方法和糟糕的报告实践。《医疗保健实践指南报告项目(右)声明清单》于2017年发布,旨在提高临床实践指南(cpg)的彻全性和报告质量。CPGs是基于证据的建议,旨在帮助临床医生在诊断和管理患者时做出决策。本研究的目的是评估美国胃肠病学学会(ACG)列出的cpg报告的完整性及其在RIGHT声明中列出的报告项目的频率。方法:采用RIGHT Statement清单中的22个标准(35个项目),两位研究人员独立记录了ACG列出的所有合格指南中每个项目的遵守情况。本研究于2018年10月1日至2018年12月5日进行。将数据记录在预先指定的Google数据抽象表上,并提取到MS Excel中进行统计分析。结果:在38个符合条件的指南中,35个RIGHT清单项目中有9个(25.7%)的依从性低于50%。平均依从性为26.8 (SD±9.5);中位依从性为30(四分位数范围21.5-33.5)。出版日期从2007年到2017年不等,其中7份指南(18.4%)出版于2007年至2009年,11份(29%)出版于2010年至2013年,20份(52.6%)出版于2014年至2017年。结论:ACG列出的CPGs报告的完整性在几个关键领域仍然不足。不遵守正确陈述清单的项目表明报告质量有改进的余地。
{"title":"Analysis of completeness of reporting utilizing the Reporting Items for practice Guidelines in Healthcare Statement in gastroenterology clinical practice guidelines.","authors":"Benjamin Howard,&nbsp;Chris Chapman,&nbsp;Chase Meyer,&nbsp;Corbin Walters,&nbsp;Matt Vassar","doi":"10.1097/XEB.0000000000000174","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000174","url":null,"abstract":"<p><strong>Aim: </strong>Assessing reporting quality is important as it allows distinctions to be made between poor methodology and poor reporting practices. The Reporting Items for practice Guidelines in Healthcare (RIGHT) Statement checklist was published in 2017 to improve the thoroughness and reporting quality of clinical practice guidelines (CPGs). CPGs are evidence-based recommendations developed to assist clinician decision-making in the diagnosis and management of patients. The aim of this study is to assess the completeness of reporting in CPGs listed by the American College of Gastroenterology (ACG) and their frequency of reporting items listed in the RIGHT Statement.</p><p><strong>Methods: </strong>Using the 22 criteria (35 items) of the RIGHT Statement checklist, two researchers independently documented the adherence to each item for all eligible guidelines listed by the ACG. This study was conducted from 01/10/18 to 05/12/18. Data were recorded onto a prespecified Google data abstraction form and extracted into MS Excel for statistical analysis.</p><p><strong>Results: </strong>Out of 38 eligible guidelines, nine of the 35 RIGHT (25.7%) checklist items were met with less than 50% adherence. The mean adherence was 26.8 (SD ± 9.5); median adherence was 30 (interquartile range 21.5-33.5). The publication dates ranged from 2007 to 2017 with seven of the guidelines (18.4%) published between 2007 and 2009, 11 (29%) published between 2010 and 2013, and 20 (52.6%) published between 2014 and 2017.</p><p><strong>Conclusion: </strong>The completeness of reporting in CPGs listed by the ACG remains inadequate in several key areas. Poor adherence to items of the RIGHT Statement checklist demonstrates that there is area for improvement in reporting quality.</p>","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"17 3","pages":"173-178"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/XEB.0000000000000174","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37371341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. 慢性斑块型银屑病的系统性药物治疗:网络荟萃分析。
Q3 Medicine Pub Date : 2019-09-01 DOI: 10.1097/XEB.0000000000000168
Jacqueline Pich
{"title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.","authors":"Jacqueline Pich","doi":"10.1097/XEB.0000000000000168","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000168","url":null,"abstract":"","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"17 3","pages":"187-188"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/XEB.0000000000000168","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37305721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 319
Phosphodiesterase 5 inhibitors for pulmonary hypertension. 磷酸二酯酶5抑制剂治疗肺动脉高压。
Q3 Medicine Pub Date : 2019-07-18 DOI: 10.1097/XEB.0000000000000198
Jacqueline Pich
{"title":"Phosphodiesterase 5 inhibitors for pulmonary hypertension.","authors":"Jacqueline Pich","doi":"10.1097/XEB.0000000000000198","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000198","url":null,"abstract":"","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81479106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
International Journal of Evidence-Based Healthcare
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1